The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses

Recently, we have shown that the administration of the tumour-targeted antibody-based immunocytokine L19-IL2 after radiotherapy (RT) resulted in synergistic anti-tumour effect. Here we show that RT and L19-IL2 can activate a curative abscopal effect, with a long-lasting immunological memory. Ionizin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rekers, Nicolle H., Olivo Pimentel, Veronica, Yaromina, Ala, Lieuwes, Natasja G., Biemans, Rianne, Zegers, Catharina M. L., Germeraad, Wilfred T. V., Van Limbergen, Evert J., Neri, Dario, Dubois, Ludwig J., Lambin, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889197/
https://www.ncbi.nlm.nih.gov/pubmed/29632732
http://dx.doi.org/10.1080/2162402X.2017.1414119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889197/
https://www.ncbi.nlm.nih.gov/pubmed/29632732
http://dx.doi.org/10.1080/2162402X.2017.1414119

Ejemplares similares